Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL17077 | |||||||
GSE147549 |
Transcriptomic profiling of human pancreatic cancer-derived cell lines MiaPACA-2 depleted of TRIP12 mRNA compared to control cells
|
8 | jerome torrisani | Apr 19, 2024 | ||||
GSE147717 |
Transcriptomic profiling of human pancreatic cancer-derived cell lines PANC-1 depleted of TRIP12 mRNA compared to control cells
|
8 | jerome torrisani | Apr 19, 2024 | ||||
GSE244527 |
Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells [Array]
|
8 | Kiyoshi Yamaguchi | Mar 31, 2024 | ||||
GSE244529 |
Wnt/β-catenin signaling regulates amino acid metabolism through the suppression of CEBPA and FOXA1 in liver cancer cells
|
26 | Kiyoshi Yamaguchi | Mar 31, 2024 | ||||
GSE260713 |
Analysis of human neuronal cells carrying ASTN2 deletion: A cross-disorder risk variant of psychiatric disorders
|
6 | Yu Hayashi | Mar 07, 2024 | ||||
GSE221056 |
Immunomodulatory drugs (IMiDs)- or cereblon E3 ligase modulator (CELMoD)-induced growth suppression of Adult T-Cell Lymphoma/Leukemia (ATL) cells and the intrinsic rolls of cereblon for down-regulation of target proteins and their down-stream effectors
|
6 | Yoshiyuki Tsukamoto | Feb 15, 2024 | ||||
GSE221062 |
Immunomodulatory drugs (IMiDs)- or cereblon E3 ligase modulator (CELMoD)-induced growth suppression of Adult T-Cell Lymphoma/Leukemia (ATL) cells and the intrinsic rolls of cereblon for down-regulation of target proteins and their down-stream effectors II
|
6 | Yoshiyuki Tsukamoto | Feb 15, 2024 | ||||
GSE236713 |
Biomarker Validation on the ‘Analysis of geNe Expression and bioMarkers fOr poiNt-of-care dEcision support in Sepsis’ (ANEMONES) study
|
447 | Karen Elizabeth Kempsell | Jan 08, 2024 | ||||
GSE243098 |
The role of NLRP3 in regulation of antimicrobial peptides and estrogen signaling in UPEC-infected bladder epithelial cells
|
12 | isak demirel | Oct 04, 2023 | ||||
GSE223523 |
Impact of miR-203-3p overexpression on human primary keratinocytes
|
6 | Kevin Lebrigand | Sep 06, 2023 | ||||
GSE239711 |
Differential Gene Expression in Monocyte macrophage lineage cells, cancer cells and fibroblasts under control or hypoxic condition
|
6 | Ryuichi Nakahara | Aug 14, 2023 | ||||
GSE119468 |
Gene expression analysis of glioblastoma (GBM) cell lines.
|
7 | Kristian Unger | Jul 01, 2023 | ||||
GSE119637 |
Multi-level characterization of a glioblastoma cell line panel
|
21 | Kristian Unger | Jul 01, 2023 | ||||
GSE221650 |
Deciphering the cardiovascular potential of human CD34+ stem cells
|
20 | Anne ARIES | May 31, 2023 | ||||
GSE208243 |
Use of DNA-alkylating pyrrole-imidazole polyamides for anti-cancer drug sensitivity screening in PDAC
|
16 | Jason Lin | Apr 25, 2023 | ||||
GSE201511 |
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells
|
12 | Hisanori Takenobu | Apr 23, 2023 | ||||
GSE148913 |
Transcriptomic profiling of human pancreatic cell lines hPNE/hTert stably over-expressing DNMTs compared to GFP-hPNE/hTert over-expressing control cells after lentiviral transduction
|
15 | jerome torrisani | Apr 20, 2023 | ||||
GSE202991 |
Gene expression data from normal human atrial cardiac fibroblasts, normal human ventricular cardiac fibroblasts, normal human dermal fibroblasts, human bone marrow-derived mesenchymal stem cells and human iPS cell-derived fibroblasts.
|
15 | Shinako Masuda | Mar 20, 2023 | ||||
GSE83853 |
Silencing miR-31 in naive CD4+ T cells by antagomiRNA
|
3 | Lingyan Zhu | Dec 24, 2022 | ||||
GSE180944 |
Long non-coding RNA TILR constitutively represses TP53 and apoptosis induction in lung cancer II
|
6 | Takashi Takahashi | Dec 19, 2022 |